Phase i and pharmacokinetic study of elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies

Giles, F J ; Vey, N ; Rizzieri, D ; Ravandi, F ; Prebet, T ; Borthakur, G ; Jacobsen, T F ; Hagen, S ; Nilsson, B ; O'Brien, S

Leukemia, 2012-01 [Periódico revisado por pares]

Springer Nature

Texto completo disponível